Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2024 08:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors

First-in-human trial confirms “Pulse-Prime” hypothesis targeting stimulation of innate and adaptive immune systemsInvestigational package of broad immune agonists derived from Gram-negative bacteria...
March 25, 2024 08:30 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting

Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural...
March 10, 2021 15:07 ET | Source: Flottman Company

SAFE PRINT 360 - DEFENDER AGAINST BACTERIA

Cincinnati, Ohio - Northern Kentucky, March 10, 2021 (GLOBE NEWSWIRE) -- Introducing Safe Print 360, Flottman Company’s new antimicrobial substrate coating, formulated to inhibit 99% of bacterial...